Dr. Martens PLC Result of AGM (9475G)

TIDMDOCS

RNS Number : 9475G

Dr. Martens PLC

29 July 2021

29 July 2021

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

29 JULY 2021

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16 to 19 as Special Resolutions.

 
                                                                                                         % Voting 
                                   Votes                                         Votes        Votes       Capital 
 Resolution                         For         %      Votes Against    %        Total       Withheld    Instructed 
                               ------------  -------                  ----- 
      Receive the 2021 
       Annual Report 
 01    and Accounts             817,208,045   100.00             918   0.00   817,208,963     286,712         81.72 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Approve the Directors' 
 02    Remuneration Report      814,391,695    99.62       3,102,787   0.38   817,494,482       1,193         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Approve the Directors' 
 03    Remuneration Policy      810,983,185    99.20       6,512,215   0.80   817,495,400         275         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Re-elect Paul 
 04    Mason                    806,609,792    98.88       9,174,649   1.12   815,784,441   1,711,234         81.58 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Re-elect Kenny 
 05    Wilson                   817,096,714    99.95         398,961   0.05   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
 06   Re-elect Jon Mortimore    814,242,068    99.60       3,253,607   0.40   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
 07   Re-elect Ian Rogers       817,494,757   100.00             918   0.00   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
 08   Re-elect Ije Nwokorie     817,255,580    99.97         240,095   0.03   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Re-elect Lynne 
 09    Weedall                  817,090,814    99.95         404,861   0.05   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Re-elect Robyn 
 10    Perriss                  809,080,897    98.97       8,414,778   1.03   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Re-elect Tara 
 11    Alhadeff                 808,826,724    98.94       8,668,033   1.06   817,494,757         918         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Re-appoint Ernst 
       & Young LLP as 
 12    auditor                  804,325,726    98.39      13,169,949   1.61   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----  ------------  ----------  ------------ 
      Authorise the 
       Audit & Risk Committee 
       to determine the 
 13    Auditor's remuneration   812,881,504    99.44       4,613,253   0.56   817,494,757         918         81.75 
     ------------------------  ------------  -------  --------------  -----  ------------  ----------  ------------ 
      Authorise the 
       Company and its 
       subsidiaries to 
       make political 
 14    donations                810,400,742    99.13       7,094,933   0.87   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Authorise allotment 
 15    of shares                785,256,734    96.06      32,238,941   3.94   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Authorise general 
       disapplication 
       of pre-emption 
 16    rights*                  817,427,469    99.99          68,206   0.01   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Authorise additional 
       disapplication 
       of pre-emption 
 17    rights*                  813,744,825    99.54       3,750,850   0.46   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Authorise purchase 
 18    of own shares*           817,175,338    99.99         100,592   0.01   817,275,930     219,745         81.73 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
      Authorise calling 
       of general meetings 
 19    on 14 days' notice*      800,175,664    97.88      17,320,011   2.12   817,495,675           0         81.75 
     ------------------------  ------------  -------  --------------  -----                ----------  ------------ 
 

*Special Resolution

The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

 
                                                                                                    % Independent 
                                 Votes                  Votes                Votes        Votes        Capital 
         Resolution               For          %       Against      %        Total       Withheld     Instructed 
 07   Re-elect Ian Rogers     388,352,317   100.00%         918   0.00%   388,353,235           0           68.03 
     ----------------------  ------------  --------  ----------  ------  ------------  ----------  -------------- 
 08   Re-elect Ije Nwokorie   388,113,140    99.94%     240,095   0.06%   388,353,235           0           68.03 
     ----------------------  ------------  --------  ----------  ------  ------------  ----------  -------------- 
      Re-elect Lynne 
 09    Weedall                387,948,374    99.90%     404,861   0.10%   388,353,235           0           68.03 
     ----------------------  ------------  --------  ----------  ------  ------------  ----------  -------------- 
      Re-elect Robyn 
 10    Perriss                379,938,457    97.83%   8,414,778   2.17%   388,353,235           0           68.03 
     ----------------------  ------------  --------  ----------  ------  ------------  ----------  -------------- 
 

Notes:

   1.    Votes "For" and "Against" are expressed as a percentage of votes received. 

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3. As at 6.30pm on 27 July 2021 the Company had a total of 1,000,000,100 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 7-10, was 570,857,660.

4. In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Enquiries

Investors and analysts

   Bethany Barnes, Director of Investor Relations                  [phone] [e-mail] 

Media

Finsbury Glover Hering

Rollo Head, James Leviton [phone]

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPPUWUMUPGGPB

(END) Dow Jones Newswires

July 29, 2021 08:06 ET (12:06 GMT)